The Share

The Diamyd Medical share is traded on Nasdaq First North (ticker : DMYD B). ISIN code: SE0005162880.

About Nasdaq First North

Nasdaq First North is an alternative marketplace operated by an exchange within the Nasdaq Group. Companies on Nasdaq First North are not subject to the same rules as companies on the regulated main market. Instead they are subject to a less extensive set of rules and regulations adjusted to small growth companies. The risk in investing in a company on Nasdaq First North may therefore be higher than investing in a company on the main market. All companies with shares traded on Nasdaq First North have a Certified Adviser who monitors that the rules are followed. The Exchange approves the application for admission to trading.

Certified Adviser at Nasdaq First North

FNCA Sweden AB, Humlegårdsgatan 5, Box 5807, SE-102 48 Stockholm. Tel: 08-528 00 399, E-mail: info@fnca.se.

Annual Report

  October 25, 2018
  Quarterly Report 1, January 23, 2019

Dear Shareholders and readers

I am pleased to report significant clinical, strategic and financial progress for this quarter. In November we reported that 11 out of 12 patients treated with intralymphatic Diamyd® in the DIAGNODE-1 trial are in partial remission about 18 months after diagnosis of type 1 diabetes. This is notable as partial remission, defined as the patient having a well-controlled blood sugar level and a low requirement for external insulin, is seen in patients that have had the disease for more than a year....

Our top strategic priority is to prepare for a marketing application for Diamyd®.
Ulf Hannelius, President and CEO

Calendar

  
March 27, 2019
Quarterly Report II
Quarterly Report 2 2018/2019
May 29, 2019
Biotech Investorkonference Q2 2019
Copenhagen, Denmark
June 26, 2019
Quarterly Report III
Quarterly Report 3 2018/2019
October 2, 2019
Year-End Report
Year-End Report 2018/2019
 

We are dedicated to finding a cure for autoimmune diabetes through pharmaceutical development and investments in medical and stem cell technologies

 

Ten largest shareholders as of January 31, 2019

ShareholderA SharesB SharesCapital %Votes %
Essen-Möller, Anders 2 556 223 7 333 040 14.30 35.69
Avanza Pension 8 312 153 12.02 9.02
Lindkvist, Bertil 6 160 000 8.91 6.68
Nordnet Pension 2 789 215 4.03 3.03
Hansen, Patrik 1 666 000 2.41 1.81
Swedbank Försäkring 1 103 920 1.60 1.20
Konstruktions o Försäljningsaktiebolag 740 000 1.07 0.80
Arandi Development AB 502 000 0.73 0.54
Relbo AB 475 550 0.69 0.52
Schelé, Sven 460 000 0.67 0.50
Remaining shareholders 37 071 695 53.6 40.2
Total 2 556 223 66 613 573 100.0 100.0